Factor II Level at Chughtai Lab

Factor II Level at Chughtai Lab

Factor II, scientifically designated as prothrombin, represents one of the foundational proteins of the human coagulation cascade. Synthesized exclusively within the hepatocytes of the liver, this vitamin K-dependent glycoprotein plays a central role in maintaining hemostasis—the physiological process that stops bleeding while maintaining fluid blood flow within the vascular system. The Factor II Level test, performed at Chughtai Lab, is a specialized hematological assay designed to measure the activity or concentration of prothrombin in a patient’s blood plasma. When vascular injury occurs, a complex sequence of enzymatic reactions is initiated, culminating in the activation of Factor X, which subsequently cleaves prothrombin (Factor II) to form thrombin (Factor IIa). Thrombin acts as the ultimate effector enzyme of the coagulation cascade, converting soluble fibrinogen into insoluble fibrin strands, which polymerize to form a stable blood clot. Additionally, thrombin stimulates platelet activation and amplifies its own generation by activating other coagulation factors, including Factors V, VIII, and XI. Consequently, any quantitative deficiency or qualitative defect in Factor II can profoundly disrupt the body’s ability to form clots, leading to severe bleeding diatheses. Conversely, elevated levels of Factor II can predispose individuals to pathological thrombosis. Chughtai Lab, utilizing advanced automated coagulation systems and adhering to stringent international quality standards, provides precise and reliable Factor II Level testing to assist clinicians in diagnosing complex bleeding disorders, monitoring hepatic synthetic function, and managing thrombotic risks.

Clinical Procedure: What to Expect

Patient Preparation

• Medication Disclosure: Patients must provide a comprehensive list of all medications, over-the-counter drugs, and herbal supplements they are currently taking. It is particularly critical to disclose the use of anticoagulants such as warfarin, heparin, low-molecular-weight heparin, or direct oral anticoagulants like rivaroxaban, apixaban, and dabigatran, as these substances directly interfere with the coagulation cascade and will alter the test results.
• Fasting Requirements: Generally, fasting is not strictly required for a Factor II Level test. However, patients should follow any specific dietary instructions provided by their referring physician, especially if other concurrent blood tests are scheduled.
• Hydration: Maintaining adequate hydration by drinking water before the procedure is highly recommended, as it facilitates easier venous access and a smoother blood draw.
• Avoid Alcohol and Strenuous Exercise: Patients are advised to refrain from consuming alcohol and engaging in vigorous physical exertion for at least 24 hours prior to the test, as these activities can temporarily influence coagulation factor levels.
• Timing of the Test: If the test is being performed to monitor therapeutic drug levels or evaluate a suspected transient deficiency, the timing of the blood draw relative to medication administration should be carefully coordinated with the healthcare provider.

During the Procedure

The patient is comfortably seated or placed in a recumbent position. The phlebotomist at Chughtai Lab will request the patient to extend their arm, exposing the antecubital fossa (the bend of the elbow). A highly trained phlebotomist will inspect the veins of the arm to select the most suitable vessel for venipuncture. A tourniquet is applied briefly above the selected site to increase venous pressure and make the vein more visible and palpable. The venipuncture site is thoroughly cleansed with an antiseptic solution (typically 70% isopropyl alcohol) using a circular motion from the center outward. The site is allowed to air dry completely to prevent hemolysis of the blood sample and minimize patient discomfort. Using a sterile, single-use needle attached to a vacuum collection system, the phlebotomist gently inserts the needle into the vein. For coagulation assays like the Factor II Level test, blood must be collected into a light blue-top tube containing a precise concentration of buffered sodium citrate (3.2%). The sodium citrate acts as an anticoagulant by chelating calcium ions, thereby preserving the coagulation factors in an inactive state until testing begins. It is clinically imperative that the collection tube is filled completely to the designated fill line to maintain the exact 9:1 ratio of blood to anticoagulant. Underfilling or overfilling the tube will invalidate the results. Immediately after collection, the tube is gently inverted 3 to 4 times to ensure thorough mixing of the blood with the sodium citrate. Vigorous shaking must be avoided to prevent hemolysis and premature platelet activation. The entire venipuncture process is virtually painless, resembling a brief pinching sensation, and is completed within two to three minutes. Once the blood is drawn, the needle is withdrawn, and immediate, gentle pressure is applied to the puncture site with a sterile gauze pad to promote hemostasis. A small adhesive bandage is applied. Patients are advised to keep the bandage on for a few hours and avoid lifting heavy objects with that arm for the remainder of the day.

When is a Factor II Level Test Performed?

Investigating Unexplained Bleeding Episodes

Physicians frequently request a Factor II Level test when a patient presents with recurrent, unexplained, or prolonged bleeding episodes. Clinical symptoms may include frequent epistaxis (nosebleeds), menorrhagia (abnormally heavy or prolonged menstrual bleeding), easy bruising (ecchymosis) without significant trauma, bleeding gums, or prolonged bleeding following minor cuts, dental extractions, or surgical procedures. Measuring the Factor II level helps determine if a deficiency in prothrombin is the underlying cause of these hemorrhagic symptoms.

Evaluating Recurrent Thrombosis (Blood Clots)

While deficiencies in Factor II lead to bleeding, certain genetic variations, such as the prothrombin G20210A mutation, cause an overproduction of Factor II. Elevated levels of prothrombin can significantly increase the risk of venous thromboembolism (VTE), including deep vein thrombosis (DVT) in the lower extremities and pulmonary embolism (PE) in the lungs. A Factor II Level test may be ordered as part of a comprehensive thrombophilia workup for patients who experience unprovoked or recurrent blood clots, especially at a young age or in unusual anatomical locations.

Monitoring Liver Function and Disease

Because the liver is the sole site of Factor II synthesis, the concentration of circulating prothrombin serves as a highly sensitive indicator of hepatic synthetic capacity. In patients with chronic liver diseases, such as liver cirrhosis, chronic hepatitis, or non-alcoholic fatty liver disease (NAFLD), as well as acute liver failure, the liver’s ability to produce clotting factors is severely compromised. Monitoring Factor II levels assists hepatologists and gastroenterologists in assessing the severity of liver dysfunction, predicting bleeding risks, and tracking disease progression.

Assessing Vitamin K Deficiency

Factor II is a vitamin K-dependent protein, meaning its synthesis requires vitamin K for the post-translational gamma-carboxylation of glutamic acid residues, which is essential for its calcium-binding capability. Vitamin K deficiency—resulting from severe dietary restriction, malabsorption syndromes (such as celiac disease, Crohn’s disease, or pancreatic insufficiency), prolonged broad-spectrum antibiotic therapy, or biliary obstruction—leads to the production of dysfunctional prothrombin. The Factor II Level test helps evaluate the functional impact of vitamin K deficiency and monitors the efficacy of vitamin K replacement therapy.

Investigating Abnormal Coagulation Screening Tests

When initial routine coagulation screening tests, such as Prothrombin Time (PT) or Activated Partial Thromboplastin Time (aPTT), yield abnormally prolonged results, a Factor II Level test is indicated as a follow-up investigation. Because Factor II is involved in the common pathway of the coagulation cascade, a deficiency will prolong both PT and aPTT. Performing a specific Factor II assay allows hematologists to pinpoint the exact factor deficiency responsible for the abnormal screening profile, distinguishing it from deficiencies in Factors V, X, or fibrinogen.

What Does a Factor II Level Test Detect?

• Congenital hypoprothrombinemia (a rare inherited bleeding disorder characterized by reduced levels of functional prothrombin).
• Congenital dysprothrombinemia (an inherited condition where normal amounts of prothrombin are produced, but the protein is structurally and functionally defective).
• Acquired Factor II deficiency secondary to end-stage liver cirrhosis.
• Acute liver failure-induced coagulopathy.
• Severe vitamin K deficiency due to chronic dietary deprivation.
• Malabsorption-related vitamin K deficiency associated with active Crohn’s disease.
• Celiac disease-associated coagulopathy resulting from impaired fat-soluble vitamin absorption.
• The therapeutic anticoagulant effect of Vitamin K antagonists such as warfarin.
• Superwarfarin poisoning or accidental ingestion of rodenticides containing long-acting anticoagulant compounds.
• Disseminated Intravascular Coagulation (DIC) during the consumptive phase, where clotting factors are rapidly depleted.
• Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS), an autoimmune condition where clearance of Factor II is accelerated.
• Neonatal hemorrhagic disease (vitamin K deficiency bleeding in newborns due to low storage and immature liver function).
• The impact of prolonged biliary obstruction (obstructive jaundice) on fat-soluble vitamin K absorption.
• Coagulopathy induced by long-term, high-dose broad-spectrum antibiotic therapy that decimates vitamin K-producing gut microbiota.
• Normal physiological levels of prothrombin, ruling out Factor II deficiency as a cause of bleeding.
• Elevated Factor II activity levels, which may correlate with an increased risk of venous thromboembolism.
• The presence of specific or non-specific Factor II inhibitors (antibodies that neutralize prothrombin activity).
• The efficacy of fresh frozen plasma (FFP) transfusion in correcting acute Factor II deficiency.
• The therapeutic response to prothrombin complex concentrate (PCC) administration in emergency bleeding situations.
• Underlying causes of unexplained prolonged Prothrombin Time (PT) and International Normalized Ratio (INR).
• Underlying causes of unexplained prolonged Activated Partial Thromboplastin Time (aPTT).
• Pre-operative bleeding risk in patients scheduled for major surgical procedures with a history of bleeding tendencies.
• Severe malnutrition-induced clotting factor deficiencies.
• The recovery of hepatic synthetic function following liver transplantation or successful treatment of acute hepatitis.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is renowned for its rapid turnaround times and highly efficient reporting systems. For specialized coagulation assays like the Factor II Level test, the processing time typically ranges from 24 to 48 hours from the time of sample collection. Once the analysis is completed and verified by a consultant hematologist, patients are immediately notified via an SMS alert. Reports can be accessed and downloaded in PDF format directly from the official Chughtai Lab website or through the user-friendly Chughtai Lab mobile application. Additionally, physical copies of the reports can be collected from any of the numerous Chughtai Lab collection centers located across Pakistan, or patients can opt to receive their reports via WhatsApp for maximum convenience.

Factor II Level Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Factor II Activity Level	70% to 120% of normal activity	Decreased (<70%) or Elevated (>120%)
Prothrombin Time (PT)	11 to 13.5 seconds	Prolonged (indicates deficiency or inhibitor)
International Normalized Ratio (INR)	0.8 to 1.2 (non-anticoagulated)	Elevated (indicates bleeding risk or therapeutic warfarin)
Activated Partial Thromboplastin Time (aPTT)	25 to 35 seconds	Prolonged (suggests common pathway defect if PT is also prolonged)
Liver Function Enzymes (ALT/AST)	Within normal limits	Elevated (suggests hepatic origin of factor deficiency)
Vitamin K Status	Normal absorption and levels	Deficient (leads to decreased functional Factor II)
Lupus Anticoagulant	Negative	Positive (may be associated with acquired Factor II deficiency)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Factor II Level?

• CAP (College of American Pathologists) accredited laboratory services, ensuring the highest international standards of diagnostic accuracy and safety.
• State-of-the-art automated coagulation analyzers that utilize advanced photo-optical and mechanical clot detection technologies.
• Highly qualified and experienced consultant hematologists and pathologists who review and validate every specialized coagulation report.
• Convenient and professional home sample collection services available across major cities in Pakistan, bringing healthcare to your doorstep.
• A vast nationwide network of modern diagnostic centers, making high-quality testing accessible to patients everywhere.
• Seamless digital report access through the Chughtai Lab mobile app, official website, SMS alerts, and WhatsApp delivery.
• Strict adherence to international quality control protocols, including regular participation in external quality assurance programs.
• A patient-centric approach focused on comfort, safety, professional phlebotomy, and timely delivery of critical diagnostic results.